Viewing Study NCT05622994

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-01-22 @ 1:16 PM
Study NCT ID: NCT05622994
Status: UNKNOWN
Last Update Posted: 2022-11-21
First Post: 2022-11-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury
Sponsor: Hospital Nacional de Parapléjicos de Toledo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Spinal Cord Injuries View
Keywords:

Keywords

Keyword Brief Keyword Text View
None walking abilities View
None Rimonabant View
None Endurance View
None Incomplete SCI View